Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3099392rdf:typepubmed:Citationlld:pubmed
pubmed-article:3099392lifeskim:mentionsumls-concept:C0038661lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C0026455lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:3099392lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:3099392pubmed:issue4787lld:pubmed
pubmed-article:3099392pubmed:dateCreated1987-2-19lld:pubmed
pubmed-article:3099392pubmed:abstractTextThe regional distributions of monoamine oxidase (MAO) types A and B have been identified in human brain in vivo with intravenously injected 11C-labeled suicide enzyme inactivators, clorgyline and L-deprenyl, and positron emission tomography. The rapid brain uptake and retention of radioactivity for both 11C tracers indicated irreversible trapping. The anatomical distribution of 11C paralleled the distribution of MAO A and MAO B in human brain in autopsy material. The corpus striatum, thalamus, and brainstem contained high MAO activity. The magnitudes of uptake of both [11C]clorgyline and L-[11C]deprenyl were markedly reduced in one subject treated with the antidepressant MAO inhibitor phenelzine. A comparison of the brain uptake and retention of the 11C-labeled inactive (D-) and active (L-) enantiomers of deprenyl showed rapid clearance of the inactive enantiomer and retention of the active enantiomer within MAO B-rich brain structures, in agreement with the known stereoselectivity of MAO B for L-deprenyl. Prior treatment with unlabeled L-deprenyl prevented retention of L-[11C]deprenyl. Thus, suicide enzyme inactivators labeled with positron emitters can be used to quantitate the distribution and kinetic characteristics of MAO in human brain structures.lld:pubmed
pubmed-article:3099392pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099392pubmed:languageenglld:pubmed
pubmed-article:3099392pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099392pubmed:citationSubsetIMlld:pubmed
pubmed-article:3099392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099392pubmed:statusMEDLINElld:pubmed
pubmed-article:3099392pubmed:monthJanlld:pubmed
pubmed-article:3099392pubmed:issn0036-8075lld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:ArnettC DCDlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:SmithMMlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:MacGregorR...lld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:FowlerJ SJSlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:SachsHHlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:WolfA PAPlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:LoganJJlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:ChristmanDDlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:DeweyS LSLlld:pubmed
pubmed-article:3099392pubmed:authorpubmed-author:SchlyerDDlld:pubmed
pubmed-article:3099392pubmed:issnTypePrintlld:pubmed
pubmed-article:3099392pubmed:day23lld:pubmed
pubmed-article:3099392pubmed:volume235lld:pubmed
pubmed-article:3099392pubmed:ownerNLMlld:pubmed
pubmed-article:3099392pubmed:authorsCompleteNlld:pubmed
pubmed-article:3099392pubmed:pagination481-5lld:pubmed
pubmed-article:3099392pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:meshHeadingpubmed-meshheading:3099392-...lld:pubmed
pubmed-article:3099392pubmed:year1987lld:pubmed
pubmed-article:3099392pubmed:articleTitleMapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.lld:pubmed
pubmed-article:3099392pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3099392pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3099392pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3099392pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099392lld:pubmed